Banking on Cell Therapy
September 15, 2017
Sitting Down With... Steve Oh, Director, Stem Cell Bioprocessing, Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), Singapore.
1 min read
August 2017
The July/August issues features a celebration of philanthropy in the pharma industry, showcasing projects at a number of companies including GlaxoSmithKline and Morningside Pharmaceuticals. Upfront investigates Eli Lilly’s advances in continuous manufacturing and the perils of a “Bad Brexit”, and in In My View, Catherine Bollard argues that scientific funding cuts in the US could be detrimental to global health. In NextGen, Stephanie Corgie gives the story of Zymtronix and its enzyme immobilization technology; and in Best Practice, Stephen Tindal and Ronak Savla argue why a fresh approach to formulation for each new molecule is the most effective. We also Sit Down With Steve Davis, President and CEO of PATH.
The Big (Bio) Freeze
September 15, 2017
When it comes to cryopreserving cell therapies, there’s a right way – and a wrong way...
1 min read
Business & Regulation
Bioprocessing
Biopharma
Cell & Gene
Facilities & Equipment
Technology & Manufacturing
Business & Trends
Gurus of Advanced Medicine
September 15, 2017
Advanced medicines, such as cell-based therapies, have the potential to revolutionize treatment, but the field is in its infancy and there are many barriers to break through. Is the pharma industry and the scientific community up to the challenge? Five gurus discuss the emerging products leading the field – and debate the future.
1 min read
What About Gene Therapies?
September 15, 2017
Gene therapy has come a long way since 1990 and the industry is seeing real advances, but there is an elephant in the room: cost.
1 min read
Being Seen and Heard
September 15, 2017
In the bustling world of cellular therapies, effective communication is essential.
1 min read
Conducting the Supply Chain Orchestra
September 15, 2017
A coordinated supply chain management plan is crucial when developing advanced therapies.
1 min read
Putting a Stop to Cell Therapy “Snake Oil”
September 15, 2017
We must close loopholes that allow patients to pay for unapproved cell therapies.
1 min read
Hype to Hope
September 15, 2017
Welcome to a special supplement focusing on one of the most exciting fields of medicine to emerge in recent years - advanced therapies.
1 min read
Listen to the Heart Beat
August 15, 2017
A consortium aims to tackle cardiovascular disease with cell therapies
1 min read
Advancing Medicine
August 9, 2017
Can cell and gene therapies paint a picture of perfect future health?
1 min read
Finding That Special Source
August 8, 2017
Bioprocesses are highly complex – and we are only now starting to fully understand the impact of cell culture media on the critical quality attributes of bio therapeutics. Here, we trace the supply chain back to raw materials and learn how fundamental research is driving advances in cell culture media.Bioprocesses are highly complex – and we are only now starting to fully understand the impact of cell culture media on the critical quality attributes of bio therapeutics. Here, we trace the supply chain back to raw materials and learn how fundamental research is driving advances in cell culture media.
1 min read
Remembering Raymond Sackler
August 7, 2017
Raymond Sackler, philanthropist, psychopharmacology pioneer, and former CEO of Purdue Pharma, dies at 97.
1 min read
Let the Molecule Decide
August 7, 2017
Formulation techniques and technologies can easily become more habit than science, but a single technology does not work for all compounds. Each new drug is unique and deserves a fresh approach to formulation.
1 min read
Catalyzing Success
August 7, 2017
Biocatalysis can bring many benefits to drug synthesis, but can enzyme immobilization enhance the process further?
1 min read
Being (Bio)Better
August 7, 2017
Why stop at biosimilar when improvements can be made? Biobetters can be challenging to develop, but offer dual rewards: more effective medicines for patients and valuable intellectual property for the developer.
1 min read
Little and Large
August 7, 2017
Big Pharma has the resources to impact millions of lives through corporate social responsibility, but charity on a smaller scale also makes a difference.
1 min read
The Value of Giving Back
August 7, 2017
Does corporate philanthropy boost pharma innovation? Fred Bereskin and Ps-Hsuan Hsu believe so.
1 min read
Discovery & Development
Business & Trends
Small Molecules
Facilities & Equipment
Technology & Manufacturing
Formulation
Drug Delivery
Doing it for the Kids
August 7, 2017
When looking to do good, many companies choose to focus on children’s health, particularly in developing countries.
1 min read
A Good Citizen
August 7, 2017
Novo Nordisk’s stated aim is “driving change to defeat diabetes and other serious chronic conditions.” And corporate social responsibility is key to delivering on that purpose.
1 min read
A Career of Responsibility – and Collaboration
August 7, 2017
Most of my career has been spent in international development – liaising with governments, local communities, businesses and foundations, aiming to improve lives and opportunities in communities around the world. And if there’s one thing I’ve learned, it’s that collaboration – across sectors, governments, communities and people- - is the key to effective social endeavors.
1 min read
Small Touches, Big Heart
August 7, 2017
It doesn’t take a big investment to make a difference – sustainable contracts and more subtle efforts can also go a long way to helping others worldwide.
1 min read
More Than PR
August 7, 2017
The first principal of corporate social responsibility is to improve lives – but goodwill and positivity are infectious.
1 min read
Heal the World
August 7, 2017
Beyond developing medicines, what is the pharma industry doing to help make the world a better place?
1 min read
Taking the Transformative PATH
August 7, 2017
Sitting Down With... Steve Davis, President and CEO of PATH, and lecturer, Social Innovation, at Stanford University, California, USA.
1 min read
Science Versus Trump
August 4, 2017
Proposed cuts to the funding of US scientific agencies will be detrimental to global health – not just the health of Americans.
1 min read
Breathe It In
August 4, 2017
The potential of inhaled drug delivery goes beyond traditional respiratory medicine.
1 min read
Testing the Boundaries
August 4, 2017
Are you compliant with the new guidelines for elemental impurities? There’s only six months left to get up to speed.
1 min read
Continuous Control
August 4, 2017
If the pharma industry wants to replace conventional batch processing with continuous manufacturing, it must also employ control procedures to ensure quality.
1 min read
The Significance of Solid Form Science
August 4, 2017
With approximately 80 percent of new drugs suffering from poor solubility and bioavailability, understanding solid form is more important than ever.
1 min read
Bad Brexit Risks Lives
August 4, 2017
An “unprecedented” joint letter from eight trade associations to Brexit negotiators warns of “supply disruptions to life-saving medicines”
1 min read
Reducing HIV Recurrence
August 4, 2017
A small molecule drug has shown the ability to diminish HIV reservoirs
1 min read
Salvagers of Solubility
August 4, 2017
High throughput excipient discovery looks set to boost oral bioavailability
1 min read
Generating Generics Faster
August 4, 2017
The FDA aims to reduce drug prices with a more competitive market
1 min read
Pharma Backs Blockchain
August 4, 2017
Will pharma adopt distributed ledger technology for data management within the next five years?
1 min read
When the Stars Align
August 4, 2017
Multistep continuous-flow manufacturing is easier said than done – especially under cGMP. But Eli Lilly has found a way with prexasertib
1 min read
One Century On
August 4, 2017
In 100 years, healthcare and medicine are likely to be vastly different to what we can predict – or even imagine.
1 min read
